Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2001, p. 2877-2884, Vol. 45, No. 10
Institut für Medizinische
Mikrobiologie, Medizinische Hochschule Hannover, 30623 Hannover,
Germany
Received 23 March 2001/Returned for modification 8 May
2001/Accepted 25 July 2001
Chromosomally acquired streptomycin resistance is frequently due to
mutations in the gene encoding the ribosomal protein S12, rpsL. The presence of several rRNA operons
(rrn) and a single rpsL gene in most
bacterial genomes prohibits the isolation of streptomycin-resistant
mutants in which resistance is mediated by mutations in the 16S rRNA
gene (rrs). Three strains were constructed in this
investigation: Mycobacterium smegmatis rrnB,
M. smegmatis rpsL3+, and M.
smegmatis rrnB rpsL3+. M. smegmatis
rrnB carries a single functional rrn
operon, i.e., rrnA (comprised of 16S, 23S, and
5S rRNA genes) and a single rpsL+
gene; M. smegmatis rpsL3+ is
characterized by the presence of two rrn operons
(rrnA and rrnB) and three
rpsL+ genes; and M. smegmatis
rrnB rpsL3+ carries a single functional
rrn operon (rrnA) and three
rpsL+ genes. By genetically altering
the number of rpsL and rrs alleles in the
bacterial genome, mutations in rrs conferring
streptomycin resistance could be selected, as revealed by analysis of
streptomycin-resistant derivatives of M. smegmatis rrnB
rpsL3+. Besides mutations well known to confer
streptomycin resistance, novel streptomycin resistance conferring
mutations were isolated. Most of the mutations were found to map to a
functional pseudoknot structure within the 530 loop region
of the 16S rRNA. One of the mutations observed, i.e., 524G
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.10.2877-2884.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mechanisms of Streptomycin Resistance: Selection of
Mutations in the 16S rRNA Gene Conferring Resistance

C,
severely distorts the interaction between nucleotides 524G and 507C, a
Watson-Crick interaction which has been thought to be essential for
ribosome function. The use of the single rRNA allelic M.
smegmatis strain should help to elucidate the principles of
ribosome-drug interactions.
*
Corresponding author. Present address: Institut
für Medizinische Mikrobiologie, Universität Zürich,
Gloriastr. 30/32, CH-8028 Zurich, Switzerland. Phone: 41-1-634-2684. Fax: 41-1-634-4906. E-mail: sander.peter{at}gmx.de.
Present address: Division of Mycology and Mycobacteriology, Faculty
of Medicine, Mahidol University, Bangkok 10700, Thailand.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»